Tapiola T - Search Results

1

Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231.

Buerger K, Zinkowski R, Teipel SJ, Tapiola T, Arai H, Blennow K, Andreasen N, Hofmann-Kiefer K, DeBernardis J, Kerkman D, McCulloch C, Kohnken R, Padberg F, Pirttilä T, Schapiro MB, Rapoport SI, Möller HJ, Davies P, Hampel H. Buerger K, et al. Among authors: tapiola t. Arch Neurol. 2002 Aug;59(8):1267-72. doi: 10.1001/archneur.59.8.1267. Arch Neurol. 2002. PMID: 12164722 Clinical Trial.

2

Differentiation of geriatric major depression from Alzheimer's disease with CSF tau protein phosphorylated at threonine 231.

Buerger K, Zinkowski R, Teipel SJ, Arai H, DeBernardis J, Kerkman D, McCulloch C, Padberg F, Faltraco F, Goernitz A, Tapiola T, Rapoport SI, Pirttilä T, Möller HJ, Hampel H. Buerger K, et al. Among authors: tapiola t. Am J Psychiatry. 2003 Feb;160(2):376-9. doi: 10.1176/appi.ajp.160.2.376. Am J Psychiatry. 2003. PMID: 12562590

3

Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.

Tapiola T, Alafuzoff I, Herukka SK, Parkkinen L, Hartikainen P, Soininen H, Pirttilä T. Tapiola T, et al. Arch Neurol. 2009 Mar;66(3):382-9. doi: 10.1001/archneurol.2008.596. Arch Neurol. 2009. PMID: 19273758

4

CSF tau and Abeta42 levels in patients with Down's syndrome.

Tapiola T, Soininen H, Pirttilä T. Tapiola T, et al. Neurology. 2001 Apr 10;56(7):979-80. doi: 10.1212/wnl.56.7.979. Neurology. 2001. PMID: 11294944 No abstract available.

5

Three-year follow-up of cerebrospinal fluid tau, beta-amyloid 42 and 40 concentrations in Alzheimer's disease.

Tapiola T, Pirttilä T, Mikkonen M, Mehta PD, Alafuzoff I, Koivisto K, Soininen H. Tapiola T, et al. Neurosci Lett. 2000 Feb 18;280(2):119-22. doi: 10.1016/s0304-3940(00)00767-9. Neurosci Lett. 2000. PMID: 10686392

6

Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B.

Leinonen V, Alafuzoff I, Aalto S, Suotunen T, Savolainen S, Någren K, Tapiola T, Pirttilä T, Rinne J, Jääskeläinen JE, Soininen H, Rinne JO. Leinonen V, et al. Among authors: tapiola t. Arch Neurol. 2008 Oct;65(10):1304-9. doi: 10.1001/archneur.65.10.noc80013. Epub 2008 Aug 11. Arch Neurol. 2008. PMID: 18695050

7

Relationship between apoE genotype and CSF beta-amyloid (1-42) and tau in patients with probable and definite Alzheimer's disease.

Tapiola T, Pirttilä T, Mehta PD, Alafuzofff I, Lehtovirta M, Soininen H. Tapiola T, et al. Neurobiol Aging. 2000 Sep-Oct;21(5):735-40. doi: 10.1016/s0197-4580(00)00164-0. Neurobiol Aging. 2000. PMID: 11016543

8

Increased aspartate aminotransferase activity in cerebrospinal fluid and Alzheimer's disease.

Tapiola T, Lehtovirta M, Pirttilä T, Alafuzoff I, Riekkinen P, Soininen H. Tapiola T, et al. Lancet. 1998 Jul 25;352(9124):287. doi: 10.1016/S0140-6736(05)60260-7. Lancet. 1998. PMID: 9690413 No abstract available.

9

CSF tau is related to apolipoprotein E genotype in early Alzheimer's disease.

Tapiola T, Lehtovirta M, Ramberg J, Helisalmi S, Linnaranta K, Riekkinen P Sr, Soininen H. Tapiola T, et al. Neurology. 1998 Jan;50(1):169-74. doi: 10.1212/wnl.50.1.169. Neurology. 1998. PMID: 9443475

10

[Use of CSF biomarkers in the diagnostics of memory diseases].

Remes A, Leikola M, Majamaa K, Nikkanen M, Ruokonen LI, Rusanen M, Tapiola T, Ylikotila P, Vallittu AM, Pirttilä T. Remes A, et al. Among authors: tapiola t. Duodecim. 2009;125(20):2215-22. Duodecim. 2009. PMID: 19998760 Finnish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39 results

Search Page

Filters